However, TBK1/IKKε inhibition by Compound II was shown to ameliorate autoimmune disease phenotypes in the Trex1-/- mouse model for Aicardi–Goutières syndrome, decreasing IFN gene signature and autoantibody titres as well as increasing survival.29 This evidence concerns the gene IKBKE and autoimmune disease.